Salarius Pharmaceuticals
$0.83439876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.8343
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.0223 (+2.90%) Today
+$0.0421 (+5.31%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell SLRX and other stocks, options, ETFs, and crypto commission-free!
About SLRX
Salarius Pharmaceuticals, Inc. Common Stock, also called Salarius Pharmaceuticals, is a clinical-stage oncology company. Read More The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company was founded in 2014 and is headquartered in Houston, TX. The listed name for SLRX is Salarius Pharmaceuticals, Inc. Common Stock.
Employees
8
Headquarters
Houston, Texas
Founded
2014
Market Cap
11.60M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
153.17K
High Today
$0.83
Low Today
$0.7737
Open Price
$0.7737
Volume
109.40K
52 Week High
$6.08
52 Week Low
$0.5552
Collections
SLRX Earnings
-$0.73
-$0.49
-$0.24
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 11, Pre-Market